Back

Results from real-world evidence and randomized controlled clinical studies with the combination of amlodipine and valsartan

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Treatment of hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Patrick Brunel

Basel (Switzerland)

10 More presentations in this session

Presentation thumbnail
Doctor M. Hameed (Birmingham, GB)
Abstract
Presentation thumbnail
Professor G. Radchenko (Kiev, UA)
Abstract Slides
Presentation thumbnail
Associate Professor W. Chang (Taipei, TW)
Abstract Slides
Presentation thumbnail
Professor Y. Dohi (Nagoya, JP)
Abstract
Presentation thumbnail
Professor H. Kai (Miyama, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Treatment of hypertension

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
25 August 2023
thumbnail
Congress Presentation
External applicability of blood pressure-lowering drug trials to real-world patients with manifest cardiovascular disease
28 August 2020
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
1 September 2025
thumbnail
Congress Presentation
Successful perindopril/amlodipine+indapamide treatment as second line in uncontrolled hypertensive patients in line with european guidelines
7 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources